New Zealand’s Centre for
Adverse Reactions Monitoring has
issued an alert under the Trans-
Tasman Early Warning System after
receiving a report of a patient who
experienced serotonin syndrome
after taking just one dose of
escitalopram.
The patient experienced
symptoms within 24 hours of taking
the dose, and while the reaction
is a predictable consequence
of excess serotonin, the report
“highlights that this syndrome
may occur after only one dose
of an SSRI, without any other
concomitant medication”.The above article was sent to subscribers in Pharmacy Daily's issue from 05 Aug 15 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 05 Aug 15
MONTU Group, its subsidiary Alternaleaf Pty Ltd, and their common director Christopher Strauch are facing legal action by the Therapeutic Goods Administration (TGA) in the Federal Court of Australia for alleged unlawful advertising on the effectiveness of their medicinal cannabis products.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.